Brand Name: BUPNEXT-N
Generic Name: Buprenorphine Hydrochloride & Naloxone Sublingual
Available Strengths:
Buprenorphine Hydrochloride & Naloxone Sublingual 2+0.5mg/ 4+0.1mg
Buprenorphine Hydrochloride & Naloxone Sublingual Tablets are a clinically trusted combination therapy used in the management of opioid dependence under professional supervision. Buprenorphine, a partial opioid agonist, helps reduce withdrawal symptoms and cravings, while Naloxone discourages misuse by blocking opioid effects if taken improperly. Together, they offer a safe, balanced, and effective treatment pathway for patients beginning recovery from opioid dependence. This combination ensures controlled, gradual stabilization and supports long-term treatment programs. Manufactured under strict regulatory and quality standards, these sublingual tablets provide consistent efficacy, safety, and reliability for de-addiction therapy protocols.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com